In the paper of Chakravarthi et al. [26], they refer to KLK4 as a protein overexpressed in prostate cancer, and KLKP1 as a transcript only expressed in normal prostate, and they claim that their fusion transcript KLK4–KLKP1 would be prostate cancer specific. Here, KLKP1 is linked to prostate carcinoma.